新綸科技(002341.SZ)子公司口罩產品生產基地加班加點積極投入生產
格隆匯2月3日丨新綸科技(002341.SZ)公佈,公司股票於2020年1月22日、2020年1月23日、2020年2月3日連續3個交易日收盤價格漲幅偏離值累計超過20%,根據深圳證券交易所的有關規定,屬於股票交易異常波動的情況。
近期,新型冠狀病毒感染的肺炎在武漢及全國多個地區出現,疫情引起了廣泛關注。隨着疫情人傳人的現象被確認,羣眾防護意識增強,防疫需求倍增,全國多地出現了口罩供應短缺。為抗擊疫情,子公司蘇州新綸超淨技術有限公司口罩產品生產基地加班加點積極投入生產;
公司子公司蘇州新綸超淨技術有限公司生產基地加班加點生產口罩事項被公共媒體報道,可能對公司股票交易價格產生影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.